Ramya Bachu

Researcher

UAMS

Last publication 2025 Last refreshed 2026-05-09

faculty

9 h-index 29 pubs 1,261 cited

Research Areas

Links

Research Group

OverviewAI-generated summary

Ramya Bachu’s research investigates advancements in the treatment of multiple myeloma, a cancer of plasma cells. Recent publications focus on CAR T-cell therapy, specifically addressing hematotoxicity associated with BCMA-directed chimeric antigen receptor T-cell therapy. Bachu has explored the use of autologous stem cell boosts to mitigate these toxicities and has examined the impact of stem cell infusion on immune effector cell-associated hematotoxicity following BCMA CAR T-cell therapy. Additionally, Bachu’s work includes studies on the psychological impact of premalignant conditions like monoclonal gammopathy of undetermined significance and smoldering multiple myeloma, as well as case series on rare presentations of multiple myeloma, such as sixth nerve palsy. Bachu has a h-index of 9 with 28 total publications and 1,248 citations. Key collaborators include Tanvi H Patel, Trilok Shrivastava, and Hira Imad Cheema, all from the University of Arkansas for Medical Sciences, with whom Bachu has multiple shared publications.

Metrics

h-index: 9
Publications: 29
Citations: 1,261

Selected Publications

Case Report: Teclistamab in the treatment of idiopathic immune thrombocytopenia in patients with multiple myeloma (2025)

DOI OpenAlex
Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP) (2024)

DOI OpenAlex
Application of Stem Cell Boost for Immune Effector Cell Associated Hematotoxicity (ICAHT) Following BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Multiple Myeloma (MM) (2024)

1 citation DOI OpenAlex
Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma (2024)

9 citations DOI OpenAlex
Exploring T cell subsets as predictors of response to BCMA targeting bispecific antibody therapy in multiple myeloma. (2024)

DOI OpenAlex
Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma (2024)

22 citations DOI OpenAlex
A Single Center Experience of T Cell Redirecting Therapy Post Stem Cell Transplantation in Relapsed Multiple Myeloma (2024)

1 citation DOI OpenAlex
Amyloid Light-Chain (AL) Amyloidosis of the Trachea Associated With an Indolent B-cell Neoplasm (2024)

DOI OpenAlex
The Effect of Stem Cell Infusion on Immune Effector Cell Associated Hematotoxicity with BCMA CAR T in Multiple Myeloma (2023)

1 citation DOI OpenAlex
Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma (2023)

DOI OpenAlex
Necrotizing Enterocolitis in a Patient With Newly Diagnosed Multiple Myeloma and Hyperviscosity Syndrome: A Case Report (2023)

1 citation DOI OpenAlex
Sixth Nerve Palsy From Multiple Myeloma in Central Nervous System: Case Series and Review of Current Literature (2023)

2 citations DOI OpenAlex
Calciphylaxis in End-Stage Renal Disease: A Rare Condition With High Mortality (2022)

2 citations DOI OpenAlex
Cerebral Venous Thrombosis Presenting as a Subacute Headache in a Young Man With Undiagnosed Factor V Leiden Mutation (2021)

2 citations DOI OpenAlex